Advertisement

Topics

SMT Research and Development Limited Company Profile

01:24 EST 19th December 2018 | BioPortfolio


News Articles [633 Associated News Articles listed on BioPortfolio]

Quotient Limited Reports Senior Note Issuance and Warrant Cash Inflows and updates on MosaiQ Development and First Quarter Fiscal 2019 Financial Results

$48.8 million of proceeds from warrant exercises received through July 31$36 million of additional senior notes issued and funded in JuneInitial SDS microarray verification and validation startedReco...

Agile research to complement agile development: a proposal for an mHealth research lifecycle

Agile research to complement agile development: a proposal for an mHealth research lifecycleAgile research to complement agile development: a proposal for an mHealth research lifecycle, Published onli...

Biopharmaceutical firm UCB to invest £1bn in UK for research and development

UCB will build a new £150mto £200m research and development facility as part of the total investment over the next five years. The transition to the facility will The post Biopharmaceutical firm UC...

NITRD requests information on AI research, development plan

The Networking and Information Technology Research and Development (NITRD) program is seeking information on the National Artificial Intelligence (AI) Research and Development Strategic Plan.

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

CatSci Appoints Paul Bradley as Head of Business Development

CatSci, a UK-based process research and development contract research organization, announced the appointment of Paul Bradley as its new head of business development. Bradley joins the team with nearl...

J&J, BARDA announce respiratory protection innovation challenge

Johnson & Johnson's Janssen Research & Development and HHS' Biomedical Advanced Research and Development Authority, along wit -More- 

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

PubMed Articles [2610 Associated PubMed Articles listed on BioPortfolio]

The relationship between exclusive breastfeeding and infant development: A 6- and 12-month follow-up study.

Breastfeeding offers several advantages for infants with research suggesting that it benefits development, including cognitive and language development. However, limited research has examined the bene...

Identifying priorities for HIV-associated tuberculosis research through the WHO guidelines process.

Guidelines developed by the WHO aim to provide recommendations to support best practice in health delivery, with a focus on low-income and middle-income countries. As part of the guideline development...

Identifying and Counting Individuals with Differences of Sex Development Conditions in Population Health Research.

The study purpose was to examine opinions about a single-item assessment of differences of sex development (DSD) to be used in research.

Reaching toward underexplored targets in antibacterial drug design.

The increase of antimicrobial resistance necessitates the renewal and strong research involvement in antibacterial drug design. In the following work, we comment on the key approaches used in developm...

Implementation of a programme to develop research projects in a school of midwifery in Santiago, Chile.

The acquisition of research skills by midwifery students is increasingly important especially for midwifery programmes in universities. Recently, universities in Chile have included the development of...

Clinical Trials [3613 Associated Clinical Trials listed on BioPortfolio]

Development of Clinical and Biological Database

The BCB is a tool: - for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic tr...

Brain Development Research Program

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...

Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU)

This study evaluates the interventions of the Cancéropôle Nord-Ouest in the development of clinical research in non-academic health institution. The randomization, in open label,determin...

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

HDClarity will seek to enroll approximately 600 research participants - 500 of whom will be at different stages of Huntington's disease (HD) and 100 healthy controls. The primary objective...

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Companies [3459 Associated Companies listed on BioPortfolio]

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Circadian Technologies Limited

Circadian Technologies Limited is an emerging leader in the field of angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs),...

AARTI INDUSTRIES LIMITED

The first unit of AARTI group, ALCHEMIE LABORATORIES, commenced commercial production of DIMETHYL SULPHATE (DMS) in the year 1975. Today, AARTI has acquired world-class expertise in the development an...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

MYCOPLASMA EXPERIENCE LIMITED

The Company was founded in 1988 by David and Helena Windsor, both ex-employees of Wellcome Research Laboratories, whose careers had centred on benchwork with mycoplasmas covering Production, Quality C...

More Information about "SMT Research and Development Limited" on BioPortfolio

We have published hundreds of SMT Research and Development Limited news stories on BioPortfolio along with dozens of SMT Research and Development Limited Clinical Trials and PubMed Articles about SMT Research and Development Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SMT Research and Development Limited Companies in our database. You can also find out about relevant SMT Research and Development Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record